CSF3 and graft versus host disease: Guo et al. reported results with the infusion of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells (including CD34+, CD3+, and NK cells) at various doses, from HLA-mismatched donors in patients with AML in first remission who were not given any GVHD prophylaxis (38).